Switch to
More onapp

How to use scorecard? Learn more

Sun Pharma Advanced Research Co Ltd

SPARC
Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,716 cr, stock is ranked 609
High RiskStock is 3.90x as volatile as Nifty
235.901.89 (-0.79%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Low

Profitability and efficiency haven't been upto the mark

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹7,716 cr, stock is ranked 609
High RiskStock is 3.90x as volatile as Nifty

Key MetricsEdit

No LabelNo Label
-19.93
PB RatioPB Ratio
15.05
Dividend YieldDiv. Yield
Sector PESector PE
44.33
Sector PBSector PB
6.05
Sector Div YldSctr Div Yld
0.57%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sun Pharma Advanced Research Company Limited is engaged in the research and experimental development on natural sciences and engineering (Pharmacy).

Financial TrendFinancial statements 

2021202220232024258.37144.09249.66105.02-151.14-203.40-222.57-387.21
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Shareholders meeting 
Announced OnJul 8, 2024

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2024 | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2024 | Download

Trading Window-XBRL 
Announced OnJun 26, 2024

Sun Pharma Advanced Research Company Limited has informed the Exchange about Closure of Trading Window | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange about Closure of Trading Window | Download

Cessation 
Announced OnJun 5, 2024

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Cessation of Mr Chetan Rajpara as Chief Financial Officer of the company w.e.f. Jun 05, 2024. | Download

Sun Pharma Advanced Research Company Limited has informed the Exchange regarding Cessation of Mr Chetan Rajpara as Chief Financial Officer of the company w.e.f. Jun 05, 2024. | Download

See all events